✦ LIBER ✦

Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies

✍ Scribed by Gregory P. Sutton; John A. Blessing; Guy Photopulos; Michael L. Berman; Howard D. Homesley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Barrett, Rolland J.; McGehee, Ramon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Phase II Study of Ifosfamide and Mesna i

✍ Gregory P. Sutton; John A. Blessing; Philip J. DiSaia; William P. McGuire 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A Phase II Gynecologic Oncology Group Tr

✍ Gregory P. Sutton; John A. Blessing; Leslie R. DeMars; David Moore; Thomas W. Bu 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Rosenshein, Neil; Photopulos, Guy; DiSaia 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Phase I Escalation of Gemcitabine Combin

✍ Agustin A. Garcia; Michael A. Bookman; Lorna Rodriguez-Rodriguez; David G. Mutch 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 61 KB

Phase I Trial of Ifosfamide and 24-h Inf

✍ Maurie Markman; David Spriggs; Robert A. Burger; Linda F. Carson; Samuel S. Lent 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 46 KB